Hui-Wen Weng

521 total citations
14 papers, 371 citations indexed

About

Hui-Wen Weng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hui-Wen Weng has authored 14 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Hui-Wen Weng's work include MicroRNA in disease regulation (3 papers), Biochemical and Molecular Research (2 papers) and RNA modifications and cancer (2 papers). Hui-Wen Weng is often cited by papers focused on MicroRNA in disease regulation (3 papers), Biochemical and Molecular Research (2 papers) and RNA modifications and cancer (2 papers). Hui-Wen Weng collaborates with scholars based in China, United States and Taiwan. Hui-Wen Weng's co-authors include Kung-Sheng Tang, Ching‐Shan Huang, Hsiu‐Chen Teng, May–Jen Huang, Cui Chen, Qiangsheng Dai, Sheng Ye, Peng Sun, Zhousan Zheng and Jiaxing Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hui-Wen Weng

14 papers receiving 360 citations

Peers

Hui-Wen Weng
Serguei A. Castañeda United States
P. Lippe Italy
Jonathan Tucci United States
A. Iop Italy
Siddesh Besur United States
Martin H. Huber United States
Charles R. Kiefer United States
Amy Broomfield Australia
M. Holtkamp Netherlands
George C. Garrow United States
Serguei A. Castañeda United States
Hui-Wen Weng
Citations per year, relative to Hui-Wen Weng Hui-Wen Weng (= 1×) peers Serguei A. Castañeda

Countries citing papers authored by Hui-Wen Weng

Since Specialization
Citations

This map shows the geographic impact of Hui-Wen Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui-Wen Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui-Wen Weng more than expected).

Fields of papers citing papers by Hui-Wen Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui-Wen Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui-Wen Weng. The network helps show where Hui-Wen Weng may publish in the future.

Co-authorship network of co-authors of Hui-Wen Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Hui-Wen Weng. A scholar is included among the top collaborators of Hui-Wen Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui-Wen Weng. Hui-Wen Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Long, Jianting, et al.. (2022). miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 4 indexed citations
2.
Weng, Hui-Wen, Yinghong Li, Wei Lin, et al.. (2022). Symptom clusters and their predictors in patients with lung cancer and treated with programmed cell death protein 1 immunotherapy. Asia-Pacific Journal of Oncology Nursing. 9(8). 100103–100103. 5 indexed citations
3.
Zheng, Xiao, et al.. (2022). Prognosis and clinical features analysis of EMT-related signature and tumor Immune microenvironment in glioma. Journal of Medical Biochemistry. 42(1). 122–137. 1 indexed citations
4.
Li, Zilun, et al.. (2020). Development and Validation of a Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer. Clinical and Applied Thrombosis/Hemostasis. 26. 2874309321–2874309321. 15 indexed citations
5.
Chen, Cui, Peng Sun, Sheng Ye, Hui-Wen Weng, & Qiangsheng Dai. (2018). Hypertension as a predictive biomarker for efficacy of bevacizumab treatment in metastatic colorectal cancer: a meta-analysis.. PubMed. 19(4). 917–24. 9 indexed citations
6.
Zheng, Zhousan, Yi Xu, Hui-Wen Weng, et al.. (2018). Over-expression of IMPDH2 is associated with tumor progression and poor prognosis in hepatocellular carcinoma.. PubMed. 8(8). 1604–1614. 14 indexed citations
7.
Zhang, Guolong, Yinghong Li, & Hui-Wen Weng. (2018). Analysis of the Frailty Condition and Influencing Factors of Elderly Patients with Lung Cancer Undergoing Chemotherapy. 18(12). 1773–1775. 1 indexed citations
8.
Xu, Yi, Zhousan Zheng, Ying Gao, et al.. (2017). High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma. Scientific Reports. 7(1). 745–745. 27 indexed citations
9.
Gao, Ying, Mengping Zhang, Zhousan Zheng, et al.. (2017). Over-expression of protein tyrosine phosphatase 4A2 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Oncotarget. 8(44). 77527–77539. 6 indexed citations
10.
Xu, Yi, Jian Rong, Shiyu Duan, et al.. (2016). High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma. Scientific Reports. 6(1). 35948–35948. 18 indexed citations
11.
Chen, Cui, Peng Sun, Jian Rong, et al.. (2015). Short Course Radiation in the Treatment of Localized Rectal cancer: A Systematic Review and Meta-Analysis. Scientific Reports. 5(1). 10953–10953. 23 indexed citations
12.
Zheng, Zhousan, Nan Shao, Hui-Wen Weng, et al.. (2014). Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma. Medical Oncology. 32(1). 275–275. 32 indexed citations
13.
Chen, Cui, Peng Sun, Qiangsheng Dai, et al.. (2014). The Glasgow Prognostic Score Predicts Poor Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma. PLoS ONE. 9(11). e112581–e112581. 38 indexed citations
14.
Huang, May–Jen, et al.. (2004). Risk Factors for Severe Hyperbilirubinemia in Neonates. Pediatric Research. 56(5). 682–689. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serguei A. Castañeda Breakdown of academic impact, for papers by P. Lippe Breakdown of academic impact, for papers by Jonathan Tucci Breakdown of academic impact, for papers by A. Iop Breakdown of academic impact, for papers by Siddesh Besur Breakdown of academic impact, for papers by Martin H. Huber Breakdown of academic impact, for papers by Charles R. Kiefer Breakdown of academic impact, for papers by Amy Broomfield Breakdown of academic impact, for papers by M. Holtkamp Breakdown of academic impact, for papers by George C. Garrow
Rankless by CCL
2026